TITLE

Valsartan reduced diabetes but not CV events in patients with impaired glucose tolerance and CV risk factors

AUTHOR(S)
Farkouh, Michael
PUB. DATE
June 2010
SOURCE
ACP Journal Club;6/15/2010, Vol. 152 Issue 6, p8
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article offers information on the clinical trial conducted on the use of the drug valsartan in adult patients with impaired glucose tolerance to reduce cardiovascular disease (CV) risk factors. The trial studied 9518 patients of 50 years of age suffering from glucose intolerance and CV disease. They were treated with valsartan and lifestyle modification program. The results showed that valsartan reduced the risk of diabetes but not CV diseases.
ACCESSION #
51696564

 

Related Articles

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics